These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19556822)

  • 1. Metastasis of lobular breast carcinoma to the uterus in a patient under anastrozole therapy.
    Ustaalioglu BB; Bilici A; Seker M; Salman T; Gumus M; Barisik NO; Salepci T; Yaylaci M
    Onkologie; 2009 Jul; 32(7):424-6. PubMed ID: 19556822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solitary uterine metastasis of invasive lobular carcinoma after adjuvant endocrine therapy: a case report.
    Toyoshima M; Iwahashi H; Shima T; Hayasaka A; Kudo T; Makino H; Igeta S; Matsuura R; Ishigaki N; Akagi K; Sakurada J; Suzuki H; Yoshinaga K
    J Med Case Rep; 2015 Feb; 9():47. PubMed ID: 25881005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lobular carcinoma of the breast metastatic to the uterus in a patient under adjuvant anastrozole therapy.
    Erkanli S; Kayaselcuk F; Kuscu E; Bolat F; Sakalli H; Haberal A
    Breast; 2006 Aug; 15(4):558-61. PubMed ID: 16311034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lobular carcinoma of the breast metastasizing to leiomyoma in a patient under letrozole treatment.
    Işçi H; Güdücü N; Basgul AY; Aydinli K; Calay Z; Dünder I
    Eur J Gynaecol Oncol; 2011; 32(5):560-2. PubMed ID: 22053676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemicentral retinal artery occlusion in a breast cancer patient using anastrozole.
    Karagöz B; Ayata A; Bilgi O; Uzun G; Unal M; Kandemir EG; Ozgün A; Türken O
    Onkologie; 2009 Jul; 32(7):421-3. PubMed ID: 19556821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology.
    Gerber B; Krause A; Reimer T; Mylonas I; Makovitzky J; Kundt G; Janni W
    Clin Cancer Res; 2006 Feb; 12(4):1245-50. PubMed ID: 16489080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine metastasis of lobular breast cancer during adjuvant letrozole therapy.
    Komeda S; Furukawa N; Kasai T; Washida A; Kobayashi H
    J Obstet Gynaecol; 2013 Jan; 33(1):99-101. PubMed ID: 23259900
    [No Abstract]   [Full Text] [Related]  

  • 8. Anastrozole-induced hepatotoxicity.
    Zapata E; Zubiaurre L; Bujanda L; Piérola A
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1233-4. PubMed ID: 17033446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
    Margolese RG; Cecchini RS; Julian TB; Ganz PA; Costantino JP; Vallow LA; Albain KS; Whitworth PW; Cianfrocca ME; Brufsky AM; Gross HM; Soori GS; Hopkins JO; Fehrenbacher L; Sturtz K; Wozniak TF; Seay TE; Mamounas EP; Wolmark N
    Lancet; 2016 Feb; 387(10021):849-56. PubMed ID: 26686957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine metastases from breast cancer in a patient under tamoxifen therapy. Case report.
    Dessole S; Cherchi PL; Ruiu GA; Meloni GB; Cossu Rocca P
    Eur J Gynaecol Oncol; 1999; 20(5-6):416-7. PubMed ID: 10609509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous adverse effects of hormonal adjuvant therapy for breast cancer: a case of localised urticarial vasculitis following anastrozole therapy and a review of the literature.
    Bock VL; Friedlander M; Waring D; Kossard S; Wood GK
    Australas J Dermatol; 2014 Nov; 55(4):282-5. PubMed ID: 24575835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Uterine metastasis of invasive lobular breast carcinoma. Case report and review of the literature with reference to differential diagnostic problems and clinical consequences].
    Kemp B; Schröder W; Hermann A; Biesterfeld S; Rath W
    Zentralbl Gynakol; 1997; 119(10):500-2. PubMed ID: 9432828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uterine and quality of life changes in postmenopausal women with an asymptomatic tamoxifen-thickened endometrium randomized to continuation of tamoxifen or switching to anastrozole.
    Van Calster B; Van Ginderachter J; Vlasselaer J; Van de Putte G; Berteloot P; Timmerman D; Depypere H; Blomme C; Vlaemynck G; De Jonge E; Van den Broecke R; Vergote I; Amant F; Van Huffel S; Neven P
    Menopause; 2011 Feb; 18(2):224-9. PubMed ID: 20881891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.
    Jakesz R; Greil R; Gnant M; Schmid M; Kwasny W; Kubista E; Mlineritsch B; Tausch C; Stierer M; Hofbauer F; Renner K; Dadak C; Rücklinger E; Samonigg H;
    J Natl Cancer Inst; 2007 Dec; 99(24):1845-53. PubMed ID: 18073378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Uterine and ovarian metastases 28 years after the discovery of breast cancer].
    Mohseni H; Truong P; Hadjseyd M; Grimonpont A; Dieny A; Mechin-Cretinon I; Chabert P
    Presse Med; 2003 Jan; 32(2):67-9. PubMed ID: 12653028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving uses of hormonal agents for breast cancer therapy.
    Cummings FJ
    Clin Ther; 2002; 24 Suppl C():C3-25. PubMed ID: 12117074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience of hormonal therapy with anastrozole for previously treated metastatic breast cancer.
    Lavrenkov K; Man S; Geffen DB; Cohen Y
    Isr Med Assoc J; 2002 Mar; 4(3):176-7. PubMed ID: 11908256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is long-term adjuvant treatment of breast cancer with anastrozole indicated?
    Doggrell SA
    Expert Opin Pharmacother; 2008 Jun; 9(9):1619-22. PubMed ID: 18518790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three years' follow-up from the ATAC trial is sufficient to change clinical practice: a debate.
    Aapro MS; Forbes JF
    Breast Cancer Res Treat; 2003; 80 Suppl 1():S3-11; discussion S13-8. PubMed ID: 14535530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the risk of bone fracture among postmenopausal women who are receiving adjuvant hormonal therapy for breast cancer.
    Bell R; Lewis J
    Curr Med Res Opin; 2007 May; 23(5):1045-51. PubMed ID: 17519070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.